Real-time enrollment status for this hematologic malignancy clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:05 PM UTC
| NCT Number | NCT05417971 |
| Recruiting Status | Recruiting |
| Condition | Hematologic Malignancy |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Northside Hospital, Inc. |
| Last Updated on CT.gov | April 16, 2026 (Apr 16, 2026) |
As of July 16, 2026: Clinical trial NCT05417971 is currently recruiting participants. This clinical trial study for hematologic malignancy is actively seeking new participants at 1 location across the United States. The study is sponsored by Northside Hospital, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05417971 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05417971 was last updated Apr 16, 2026 (April 16, 2026). HelloStudys verifies this status automatically.